Your session is about to expire
← Back to Search
Other
Iron-Fortified Formula for Infant Development
Phase 3
Recruiting
Led By Keith Aqua, MD
Research Sponsored by Aussie Bubs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks of clinical study
Awards & highlights
No Placebo-Only Group
Pivotal Trial
Summary
This trial studies the effects of a special baby formula on the growth of healthy infants over a few months. The goal is to see if the added nutrients help babies gain weight and develop normally. Babies will be fed as much formula as they want during this period. The American Academy of Pediatrics has strongly advocated nutrient fortification of infant formulas since 1969 to reduce the prevalence of iron-deficiency anemia.
Who is the study for?
This trial is for healthy babies born at full term. It's not suitable for infants with health issues that could affect how they feed or grow.
What is being tested?
The study tests the growth effects of iron-fortified infant formula over a period of 4 months, monitoring weight gain and overall development in these infants.
What are the potential side effects?
While not explicitly stated, potential side effects may include digestive discomfort or allergic reactions to ingredients in the formula.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks of clinical study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks of clinical study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Weight gain (g) from study entry to 16 weeks of study.
Secondary study objectives
Head Circumference gain (cm) from study entry to 16 weeks of study
Recumbent length gain (cm) from study entry to 16 weeks of study.
Tolerance of study formulas over 16 weeks of study
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Study Formula 3_Cow's Milk Infant Formula void of A1-BetaCaseinExperimental Treatment1 Intervention
Infant Formula meets all nutrient requirements of the FDA.
Group II: Study Formula 2_Goat Milk Infant FormulaExperimental Treatment1 Intervention
Infant Formula meets all nutrient requirements of the FDA.
Group III: Study Formula 1_365 Day Grass-Fed Cow's Milk Infant FormulaExperimental Treatment1 Intervention
Infant formula meets all nutrient requirements of the FDA.
Group IV: Study Formula 4_USDA Organic iron fortified infant formulaActive Control1 Intervention
Infant Formula meets all nutrient requirements of the FDA.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Iron-fortified infant formulas work by providing essential nutrients, particularly iron, which is vital for the production of hemoglobin and oxygen transport in the blood. Adequate iron levels are crucial for cognitive and psychomotor development in infants.
These formulas help prevent iron deficiency anemia, which can lead to developmental delays and impaired growth. By ensuring sufficient iron intake, iron-fortified formulas support overall growth, brain development, and the prevention of developmental issues in infants.
[Treatment of anemia in pregnancy].A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan.Effect of chronic erythropoietin administration on plasma iron in newborn lambs.
[Treatment of anemia in pregnancy].A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan.Effect of chronic erythropoietin administration on plasma iron in newborn lambs.
Find a Location
Who is running the clinical trial?
Aussie Bubs, Inc.Lead Sponsor
Keith Aqua, MDPrincipal InvestigatorBacktee Holdings, LLC
1 Previous Clinical Trials
570 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My baby was born at full term and is healthy.
Research Study Groups:
This trial has the following groups:- Group 1: Study Formula 1_365 Day Grass-Fed Cow's Milk Infant Formula
- Group 2: Study Formula 2_Goat Milk Infant Formula
- Group 3: Study Formula 3_Cow's Milk Infant Formula void of A1-BetaCasein
- Group 4: Study Formula 4_USDA Organic iron fortified infant formula
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.